HEADER PEPTIDE BINDING PROTEIN/PEPTIDE 26-JUL-09 2WOK TITLE CLAVULANIC ACID BIOSYNTHESIS OLIGOPEPTIDE BINDING PROTEIN 2 COMPLEXED TITLE 2 WITH BRADYKININ COMPND MOL_ID: 1; COMPND 2 MOLECULE: CLAVULANIC ACID BIOSYNTHESIS OLIGOPEPTIDE BINDING PROTEIN COMPND 3 2; COMPND 4 CHAIN: A; COMPND 5 SYNONYM: ORF15; COMPND 6 ENGINEERED: YES; COMPND 7 MOL_ID: 2; COMPND 8 MOLECULE: KININOGEN-1; COMPND 9 CHAIN: B; COMPND 10 SYNONYM: BRADYKININ,ALPHA-2-THIOL PROTEINASE INHIBITOR,FITZGERALD COMPND 11 FACTOR,HIGH MOLECULAR WEIGHT KININOGEN,HMWK,WILLIAMS-FITZGERALD- COMPND 12 FLAUJEAC FACTOR; COMPND 13 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: STREPTOMYCES CLAVULIGERUS; SOURCE 3 ORGANISM_TAXID: 1901; SOURCE 4 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 5 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 6 MOL_ID: 2; SOURCE 7 SYNTHETIC: YES; SOURCE 8 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 9 ORGANISM_COMMON: HUMAN; SOURCE 10 ORGANISM_TAXID: 9606 KEYWDS PEPTIDE BINDING PROTEIN-PEPTIDE COMPLEX, SOLUTE-BINDING PROTEIN, KEYWDS 2 CLAVULANIC ACID BIOSYNTHESIS, OLIGOPEPTIDE BINDING PROTEIN, KEYWDS 3 OLIGOPEPTIDE, BRADYKININ EXPDTA X-RAY DIFFRACTION AUTHOR A.K.MACKENZIE,K.VALEGARD,A.IQBAL,M.E.C.CAINES,N.J.KERSHAW,S.E.JENSEN, AUTHOR 2 C.J.SCHOFIELD,I.ANDERSSON REVDAT 4 20-DEC-23 2WOK 1 REMARK REVDAT 3 12-DEC-18 2WOK 1 COMPND SOURCE AUTHOR JRNL REVDAT 3 2 1 DBREF REVDAT 2 09-FEB-10 2WOK 1 KEYWDS JRNL REVDAT 1 08-DEC-09 2WOK 0 JRNL AUTH A.K.MACKENZIE,K.VALEGARD,A.IQBAL,M.E.CAINES,N.J.KERSHAW, JRNL AUTH 2 S.E.JENSEN,C.J.SCHOFIELD,I.ANDERSSON JRNL TITL CRYSTAL STRUCTURES OF AN OLIGOPEPTIDE-BINDING PROTEIN FROM JRNL TITL 2 THE BIOSYNTHETIC PATHWAY OF THE BETA-LACTAMASE INHIBITOR JRNL TITL 3 CLAVULANIC ACID. JRNL REF J. MOL. BIOL. V. 396 332 2010 JRNL REFN ESSN 1089-8638 JRNL PMID 19941870 JRNL DOI 10.1016/J.JMB.2009.11.045 REMARK 2 REMARK 2 RESOLUTION. 1.70 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.2.0019 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.70 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 62.14 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 99.8 REMARK 3 NUMBER OF REFLECTIONS : 56831 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.187 REMARK 3 R VALUE (WORKING SET) : 0.185 REMARK 3 FREE R VALUE : 0.223 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 3022 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.70 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.74 REMARK 3 REFLECTION IN BIN (WORKING SET) : 4158 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 98.74 REMARK 3 BIN R VALUE (WORKING SET) : 0.2300 REMARK 3 BIN FREE R VALUE SET COUNT : 219 REMARK 3 BIN FREE R VALUE : 0.2910 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4359 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 12 REMARK 3 SOLVENT ATOMS : 380 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 19.20 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 18.12 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -1.06000 REMARK 3 B22 (A**2) : 1.54000 REMARK 3 B33 (A**2) : -0.45000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.18000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.113 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.111 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.077 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 2.322 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.956 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.938 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 4499 ; 0.014 ; 0.021 REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 6157 ; 1.464 ; 1.971 REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 560 ; 5.674 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 219 ;29.159 ;22.283 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 651 ;12.695 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 54 ;19.913 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 673 ; 0.097 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 3577 ; 0.006 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): 2159 ; 0.202 ; 0.200 REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): 3062 ; 0.308 ; 0.200 REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): 359 ; 0.129 ; 0.200 REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): 41 ; 0.126 ; 0.200 REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): 19 ; 0.099 ; 0.200 REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 2850 ; 0.887 ; 1.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 4529 ; 1.395 ; 2.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 1825 ; 2.354 ; 3.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 1626 ; 3.803 ; 4.500 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS. REMARK 4 REMARK 4 2WOK COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 26-JUL-09. REMARK 100 THE DEPOSITION ID IS D_1290040549. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 10-DEC-07 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 8 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : ID14-3 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.931 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : M REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 59885 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.700 REMARK 200 RESOLUTION RANGE LOW (A) : 62.100 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.7 REMARK 200 DATA REDUNDANCY : 3.700 REMARK 200 R MERGE (I) : 0.10000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 18.0000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.70 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.74 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.8 REMARK 200 DATA REDUNDANCY IN SHELL : 3.70 REMARK 200 R MERGE FOR SHELL (I) : 0.44000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.600 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: PDB ENTRY 2WOL REMARK 200 REMARK 200 REMARK: NONE REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 46.00 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.30 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PH 8 REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 41.66350 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 1560 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 21380 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -5.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 1 REMARK 465 THR A 2 REMARK 465 THR A 3 REMARK 465 ALA A 4 REMARK 465 ALA A 5 REMARK 465 ARG A 6 REMARK 465 ARG A 7 REMARK 465 GLU A 561 REMARK 465 ASP A 562 REMARK 465 SER B 6 REMARK 465 PRO B 7 REMARK 465 PHE B 8 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LYS A 401 CG CD CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 OE1 GLU A 87 O HOH A 2070 2.14 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASP A 84 -85.10 -119.96 REMARK 500 ARG A 149 69.31 -154.53 REMARK 500 ASP A 208 67.18 -159.55 REMARK 500 ASP A 223 12.83 59.53 REMARK 500 THR A 224 -55.88 -133.02 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GOL A 1561 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GOL A 1562 REMARK 800 REMARK 800 SITE_IDENTIFIER: BRD REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR CHAIN B REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 2WOL RELATED DB: PDB REMARK 900 CLAVULANIC ACID BIOSYNTHESIS OLIGOPEPTIDE PERMEASE-LIKE BINDING REMARK 900 PROTEIN 2 REMARK 900 RELATED ID: 2WOP RELATED DB: PDB REMARK 900 CLAVULANIC ACID BIOSYNTHESIS OLIGOPEPTIDE PERMEASE-LIKE BINDING REMARK 900 PROTEIN 2 COMPLEXED WITH ARGININE DBREF 2WOK A 1 562 UNP Q8KRB4 Q8KRB4_STRCL 1 562 DBREF 2WOK B 1 9 UNP P01042 KNG1_HUMAN 381 389 SEQRES 1 A 562 MET THR THR ALA ALA ARG ARG PRO ALA PRO THR THR ALA SEQRES 2 A 562 GLY ALA GLY TRP ASP ALA GLY VAL GLY ALA LEU VAL ASN SEQRES 3 A 562 PRO SER ARG ARG ARG GLY GLY THR LEU ARG LEU VAL SER SEQRES 4 A 562 SER ALA ASP VAL ASP SER LEU ASP PRO ALA ARG THR TYR SEQRES 5 A 562 TYR VAL TRP VAL TRP LEU LEU GLN ARG LEU LEU ASN ARG SEQRES 6 A 562 THR LEU MET ALA TYR PRO THR ASP PRO GLY PRO ALA GLY SEQRES 7 A 562 LEU VAL PRO ALA PRO ASP LEU ALA GLU GLY PRO GLY GLU SEQRES 8 A 562 VAL SER ASP GLY GLY ARG THR TRP THR TYR ARG LEU ARG SEQRES 9 A 562 ARG GLY LEU ARG TYR ASP ASP GLY THR PRO ILE THR SER SEQRES 10 A 562 ASP ASP VAL ARG HIS ALA VAL GLN ARG VAL PHE ALA GLN SEQRES 11 A 562 ASP VAL LEU PRO GLY GLY PRO THR TYR LEU ILE PRO LEU SEQRES 12 A 562 LEU ASP ASP PRO GLU ARG PRO TYR PRO GLY PRO TYR ARG SEQRES 13 A 562 THR ASP GLU PRO LEU ARG SER VAL LEU THR PRO ASP GLU SEQRES 14 A 562 HIS THR ILE VAL PHE ARG LEU THR ARG PRO PHE SER ASP SEQRES 15 A 562 PHE ASP HIS LEU MET ALA GLN PRO CYS ALA ALA PRO VAL SEQRES 16 A 562 PRO ARG ARG SER ASP THR GLY ALA ASP TYR GLY ARG ASP SEQRES 17 A 562 PRO ARG SER SER GLY PRO TYR ARG VAL ALA ARG HIS GLU SEQRES 18 A 562 PRO ASP THR LEU LEU HIS LEU GLU ARG ASN PRO HIS TRP SEQRES 19 A 562 ASP ARG ALA THR ASP PRO ILE ARG PRO ALA LEU PRO ASP SEQRES 20 A 562 ARG VAL GLU LEU THR ILE GLY LEU ASP VAL ASP VAL LEU SEQRES 21 A 562 ASP ALA ARG LEU ILE ALA GLY GLU PHE ASP ILE ASN LEU SEQRES 22 A 562 GLU GLY ARG GLY LEU GLN HIS ALA ALA GLN ARG ARG ALA SEQRES 23 A 562 THR ALA ASP GLU VAL LEU ARG SER HIS THR ASP ASN PRO SEQRES 24 A 562 ARG THR SER PHE LEU HIS PHE VAL ALA MET GLN PRO HIS SEQRES 25 A 562 ILE PRO PRO PHE ASP ASN VAL HIS VAL ARG ARG ALA VAL SEQRES 26 A 562 GLN TYR ALA ALA ASP LYS ILE LEU LEU GLN ASP ALA ARG SEQRES 27 A 562 GLY GLY PRO VAL ASN GLY GLY ASP LEU THR THR ALA LEU SEQRES 28 A 562 PHE PRO PRO THR LEU PRO ALA HIS GLN ASP LEU ASP LEU SEQRES 29 A 562 TYR PRO THR GLY PRO ASP LEU ARG GLY ASP LEU ASP ALA SEQRES 30 A 562 ALA ARG ALA GLU LEU ALA ALA ALA GLY LEU PRO ASP GLY SEQRES 31 A 562 PHE ARG ALA VAL ILE GLY THR GLN ARG GLY LYS PHE ARG SEQRES 32 A 562 LEU VAL ALA ASP ALA VAL VAL GLU SER LEU ALA ARG VAL SEQRES 33 A 562 GLY ILE GLU LEU THR VAL LYS GLU LEU ASP VAL ALA THR SEQRES 34 A 562 TYR PHE SER LEU GLY ALA GLY HIS PRO GLU THR VAL ARG SEQRES 35 A 562 GLU HIS GLY LEU GLY LEU LEU VAL THR ASP TRP GLY ALA SEQRES 36 A 562 ASP PHE PRO THR GLU TYR GLY PHE LEU ALA PRO LEU VAL SEQRES 37 A 562 ASP GLY ARG GLN ILE LYS ARG ASN GLY GLY ASN TRP ASN SEQRES 38 A 562 LEU PRO GLU LEU ASP ASP PRO GLU VAL ASN ALA LEU ILE SEQRES 39 A 562 ASP GLU THR LEU HIS THR THR ASP PRO ALA ALA ARG ALA SEQRES 40 A 562 GLU LEU TRP ARG ALA VAL GLU ARG ARG VAL MET GLU HIS SEQRES 41 A 562 ALA VAL LEU LEU PRO LEU VAL HIS ASP LYS THR LEU HIS SEQRES 42 A 562 PHE ARG ASN PRO TRP VAL THR ASN VAL TYR VAL HIS PRO SEQRES 43 A 562 ALA PHE GLY LEU TYR ASP ILE GLN ALA MET GLY LEU ALA SEQRES 44 A 562 GLU GLU ASP SEQRES 1 B 9 ARG PRO PRO GLY PHE SER PRO PHE ARG HET GOL A1561 6 HET GOL A1562 6 HETNAM GOL GLYCEROL HETSYN GOL GLYCERIN; PROPANE-1,2,3-TRIOL FORMUL 3 GOL 2(C3 H8 O3) FORMUL 5 HOH *380(H2 O) HELIX 1 1 PRO A 8 THR A 12 5 5 HELIX 2 2 TYR A 53 ASN A 64 1 12 HELIX 3 3 THR A 116 VAL A 127 1 12 HELIX 4 4 TYR A 139 ASP A 145 1 7 HELIX 5 5 ASP A 182 ALA A 188 1 7 HELIX 6 6 GLN A 189 ALA A 193 5 5 HELIX 7 7 PRO A 196 ASP A 200 5 5 HELIX 8 8 ASP A 235 ASP A 239 5 5 HELIX 9 9 ASP A 256 ALA A 266 1 11 HELIX 10 10 GLN A 279 ASP A 289 1 11 HELIX 11 11 ASP A 289 SER A 294 1 6 HELIX 12 12 ASN A 318 ALA A 329 1 12 HELIX 13 13 ASP A 330 ARG A 338 1 9 HELIX 14 14 ASP A 374 ALA A 385 1 12 HELIX 15 15 LYS A 401 ARG A 415 1 15 HELIX 16 16 HIS A 437 HIS A 444 1 8 HELIX 17 17 LEU A 464 ASP A 469 1 6 HELIX 18 18 ASP A 487 HIS A 499 1 13 HELIX 19 19 ASP A 502 ALA A 521 1 20 HELIX 20 20 ASP A 552 MET A 556 5 5 SHEET 1 AA 5 TYR A 215 GLU A 221 0 SHEET 2 AA 5 LEU A 225 ARG A 230 -1 O LEU A 225 N GLU A 221 SHEET 3 AA 5 ARG A 248 THR A 252 -1 O VAL A 249 N LEU A 228 SHEET 4 AA 5 LEU A 35 VAL A 38 1 O LEU A 35 N GLU A 250 SHEET 5 AA 5 ILE A 271 ASN A 272 1 O ILE A 271 N VAL A 38 SHEET 1 AB 2 MET A 68 ALA A 69 0 SHEET 2 AB 2 ALA A 82 PRO A 83 -1 O ALA A 82 N ALA A 69 SHEET 1 AC 4 VAL A 92 SER A 93 0 SHEET 2 AC 4 THR A 98 ARG A 102 -1 O THR A 98 N SER A 93 SHEET 3 AC 4 THR A 171 ARG A 175 -1 O ILE A 172 N TYR A 101 SHEET 4 AC 4 VAL A 164 ASP A 168 -1 O LEU A 165 N VAL A 173 SHEET 1 AD 2 THR A 296 ASP A 297 0 SHEET 2 AD 2 HIS A 533 PHE A 534 -1 O HIS A 533 N ASP A 297 SHEET 1 AE 3 LEU A 449 TRP A 453 0 SHEET 2 AE 3 ARG A 300 ALA A 308 -1 O LEU A 304 N TRP A 453 SHEET 3 AE 3 LEU A 523 LYS A 530 -1 O LEU A 524 N VAL A 307 SHEET 1 AF 2 ARG A 392 ILE A 395 0 SHEET 2 AF 2 GLU A 419 VAL A 422 1 O GLU A 419 N ALA A 393 CISPEP 1 PRO A 314 PRO A 315 0 1.87 CISPEP 2 GLY A 340 PRO A 341 0 8.31 SITE 1 AC1 11 TRP A 57 TYR A 70 ALA A 455 ASP A 456 SITE 2 AC1 11 PRO A 458 ALA A 547 GOL A1562 HOH A2055 SITE 3 AC1 11 HOH A2377 HOH A2378 ARG B 1 SITE 1 AC2 10 THR A 301 SER A 302 PHE A 303 GLY A 454 SITE 2 AC2 10 ALA A 455 ALA A 547 PHE A 548 GOL A1561 SITE 3 AC2 10 HOH A2379 ARG B 1 SITE 1 BRD 15 TYR A 52 VAL A 54 TRP A 57 PHE A 303 SITE 2 BRD 15 GLN A 398 PHE A 402 PHE A 431 ASP A 452 SITE 3 BRD 15 TRP A 453 GLY A 454 ALA A 455 ASP A 456 SITE 4 BRD 15 TRP A 480 GOL A1561 GOL A1562 CRYST1 53.511 83.327 62.380 90.00 95.54 90.00 P 1 21 1 2 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.018688 0.000000 0.001813 0.00000 SCALE2 0.000000 0.012001 0.000000 0.00000 SCALE3 0.000000 0.000000 0.016106 0.00000